Three Seasons Wealth, LLC Spero Therapeutics, Inc. Transaction History
Three Seasons Wealth, LLC
- $205 Billion
- Q4 2024
A detailed history of Three Seasons Wealth, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Three Seasons Wealth, LLC holds 30,000 shares of SPRO stock, worth $25,200. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$25,200% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding SPRO
# of Institutions
53Shares Held
14.9MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.84MShares$3.23 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.48 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.14 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$928,6960.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.04MShares$873,5340.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $29.5M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...